How do I find clinical trials for CLL
Ask Navis about your situation
This answer is general. Get one about your specific case. No signup, answered right here.
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Sources & medical oversight
- Grounded in NCCN Guidelines for Patients: Chronic Lymphocytic Leukemia — the same guidelines oncologists use.
- Developed under the medical oversight of OpenCancer’s physician-scientist team (Chris Apfel, MD/PhD/MBA, CMO · Kaumudi Bhawe, PhD, CSO).
- Last updated May 17, 2026. Informational only — not a substitute for your oncology team.
Finding Clinical Trials for CLL
I'm glad you're exploring clinical trial options—they can offer access to newer treatments and contribute to advancing CLL care. Here's a practical guide to finding trials that might be right for you.
Where to Search for CLL Clinical Trials
1. ClinicalTrials.gov (Primary Resource)
- Go to www.clinicaltrials.gov
- Search for "chronic lymphocytic leukemia" or "CLL"
- Filter by:
- Location (your state/region)
- Trial status (recruiting, not yet recruiting)
- Phase (Phase 1, 2, 3, or 4)
- Sponsor (academic centers, pharmaceutical companies, NIH)
2. Cancer-Specific Trial Databases
- National Cancer Institute (NCI): cancer.gov/about-cancer/treatment/clinical-trials
- American Cancer Society: cancer.org/treatment/find-clinical-trials
- Leukemia & Lymphoma Society: lls.org/clinical-trials (specifically focused on blood cancers like CLL)
3. Your Treatment Center
- Ask your oncologist directly about trials they're running or know about
- Many academic medical centers have dedicated clinical trial coordinators
- Your hospital may have trials not yet listed on public databases
What to Look For in a CLL Trial
Key Information to Understand:
- Trial Phase: Phase 1 (safety), Phase 2 (effectiveness), Phase 3 (comparison to standard treatment)
- Eligibility criteria: Your disease stage, prior treatments, blood counts, organ function
- Primary endpoint: What the trial is measuring (response rate, survival, side effects)
- Treatment approach: Targeted therapy, immunotherapy, chemotherapy, or combination
- Location and travel requirements: Some trials require frequent visits
Questions to Ask Your Oncologist About Trials
- "Are there any CLL trials at our center or nearby that match my specific disease characteristics?"
- "How does this trial's treatment compare to my current standard treatment options?"
- "What are the potential benefits and risks specific to my situation?"
- "What does participation involve—how often would I need to visit, and what tests are required?"
- "Can I stop the trial if I experience side effects, and what happens to my care then?"
Important Considerations
- You own your health data: According to guidance on patient data rights, you have the right to access your clinical trial data and understand how your information is being used
- Informed consent is essential: Make sure you fully understand what participation means before enrolling
- Standard care continues: Most trials don't replace your regular CLL treatment—they add to it or offer an alternative
Additional Resources
The Leukemia & Lymphoma Society (lls.org) is particularly valuable for CLL patients because they maintain disease-specific trial information and can connect you with patient advocates who've navigated trial participation.
According to NCCN Guidelines for CLL, clinical trials are considered an important treatment option at all stages of disease, especially for patients with relapsed or refractory CLL (disease that doesn't respond to standard treatment).
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
Ask Navis about your case
That answer is general. Ask about your specific situation. No signup, answered right here.
Facing this with someone you love?
Keep the whole picture in one private place: records, a plain-language summary of where things stand, questions, and the people helping. Navis keeps it up to date so no one has to re-explain the story. Free, and only the people you invite can ever see it.
Start a care circle →Source Guidelines
NCCN Guidelines for Patients: Chronic Lymphocytic Leukemia (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for CLL patients
Have your records handy? Upload them for a deeper, personalized analysis →
Related Questions
Medicare part A and gap coverage with Anthem
I can't answer specific insurance coverage questions—that requires checking your actual policy details and your plan's current formulary drug list. W
Is Obinutuzumsb and Ventoclax covered as a first line treatment for CLL
I'm Brad, an AI assistant here to help you understand your CLL care. Looking at the NCCN Guidelines for CLL the standard treatment guidelines oncolog
What are the treatment options for CLL
According to the NCCN Guidelines for Chronic Lymphocytic Leukemia, here are the main treatment approaches: First-Line Treatments Initial therapy - B